Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

Vaxart Inc (VXRT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Vaxart's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.7586 +0.0297    +4.07%
15:18:44 - Real-time Cboe. Currency in USD ( Disclaimer )
  • Volume: 817,829
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.7310 - 0.7796
Type:  Equity
Market:  United States
Vaxart 0.7586 +0.0297 +4.07%

Vaxart Inc Company Profile

 
Get an in-depth profile of Vaxart Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

109

Equity Type

ORD

Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company’s product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.

Contact Information

Address 170 Harbor Way Suite 300
South San Francisco, 94080
United States
Phone 650 550 3500
Fax 650 871 8580

Top Executives

Name Age Since Title
David E. Wheadon 65 2021 Independent Lead Director
James Robinson 63 - Member of Manufacturing & Quality Advisory Board
Steven Lo 57 2024 President, CEO & Director
Stefan Gravenstein - 2021 Member of Scientific & Clinical Advisory Board
Gregory C. Gray - 2021 Member of Scientific & Clinical Advisory Board
John F. Carpenter - 2021 Member of Manufacturing & Quality?Advisory?Board
Robert B. Belshe - 2021 Member of Scientific & Clinical Advisory Board
Benjamin J. Del Tito 68 2021 Member of Manufacturing & Quality?Advisory?Board
George R. Siber 79 2021 Member of Scientific & Clinical Advisory Board
Harry B. Greenberg - 2021 Member of Scientific & Clinical Advisory Board
Ralph Baric - 2021 Member of Scientific & Clinical Advisory Board
Marion Pepper - 2021 Member of Scientific & Clinical Advisory Board
Vijay Jethwa - 2021 Member of Manufacturing & Quality?Advisory?Board
Michael J. Finney 65 2018 Independent Chairman of the Board
William Mark Watson 74 2022 Independent Director
Elaine J. Heron 76 2022 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

VXRT Comments

Write your thoughts about Vaxart Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Andrew Zazulyak
Andrew Zazulyak Feb 03, 2022 21:20
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bbgck
Anam Piracha
Anam Piracha Sep 04, 2020 12:56
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why did this coming to $4 from $16? Is there any hope?
John Van Dalen
John Van Dalen Sep 04, 2020 12:56
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Moe Zarand
Moe Zarand Jul 27, 2020 11:07
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any longterm hope on this?
dhruval soni
dhruval soni Jul 20, 2020 15:53
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Is it sell or hold at 15.13
Austin Chauhan
Austin Chauhan Jul 20, 2020 15:53
Saved. See Saved Items.
This comment has already been saved in your Saved Items
its a sell, because it was around 38 cents when i bought it, and now it will keep going down foe a wgile before it picks up
Ermias Abraham
Ermias Abraham Jul 19, 2020 11:23
Saved. See Saved Items.
This comment has already been saved in your Saved Items
16$ is good entry. Buy and hold. got it at 15. By december , will reach over 100$
Ermias Abraham
Ermias Abraham Jul 19, 2020 11:20
Saved. See Saved Items.
This comment has already been saved in your Saved Items
THis stock will soar to $100 and over. Will follow NVAX
Dillon Pusta
Dillon Pusta Jul 19, 2020 11:20
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sheres the info on this?
Moe Zarand
Moe Zarand Jul 17, 2020 10:45
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Is 16$ a good entry?
Iain Fyles
Iain Fyles Jul 15, 2020 21:49
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this is a 100$ stock
George Peters
George Peters Jul 09, 2020 11:58
Saved. See Saved Items.
This comment has already been saved in your Saved Items
NIAID creates new COVID-19 drug and vaccine trial network through Trump's Warp Speed programby Ben Adams |  Jul 9, 2020 7:55am
George Peters
George Peters Jun 29, 2020 9:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
"Vaxart’s COVID-19 Vaccine Selected for the U.S. Government’s Operation Warp Speed OWS to Test First Oral COVID-19 Vaccine in Non-Human Primates
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email